Misoprostol

米索前列醇

Report date: 2026/03/13 20:02:36
NME

Base Information

Drug NameMisoprostol
Drug Alias Name迷索前列醇VagiprostMysodelleMisopessIsprelor +[12
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionProstanoid EP2 receptor agonists
TargetsProstanoid EP2 receptor
Therapy Area/IndicationsLabor, InducedContraceptionTerminate pregnancy +[37
Global Approved IndicationsTerminate pregnancyStomach UlcerDuodenal Ulcer +[5
Approved Indications in ChinaTerminate pregnancy
Original Approved Country/TerritorySwitzerland
Original Approved Date1984/06/28
Country/TerritoryCanadaUnited StatesVietnam +[21
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesPfizer Inc
China Registration ClassN/A

Develop Information

Active IndicationsLabor, InducedTerminate pregnancyObesity, Morbid +[11
Inactive IndicationsContraceptionIntrauterine Device MigrationPain +[26

Other Information

ATC CodeA02BB01G02AD06